{
  "documentMetadata": {
    "title": "Post-Streptococcal Reactive Arthritis",
    "lastUpdated": "2025-04-22",
    "sourceFile": "Arthritis, Post-Streptococcal.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Immunologic reaction after streptococcal pharyngitis, usually in children.",
        "Post-streptococcal reactive arthritis (PSRA) is a distinct entity from Acute Rheumatic Fever (ARF)",
        "Onset of PSRA occurs about 10 days after pharyngitis (14-21 days in ARF)",
        "Arthritis of PSRA is cumulative, persistent, involves large, small, and axial joints (arthritis of ARF is migratory, transient, involves large joints)",
        "PSRA responds less well to aspirin, whereas arthritis of ARF responds rapidly",
        "Increased HLA DRB1*01 expression",
        "Aseptic arthritis with evidence of prior streptococcal infection.",
        "Elevated ESR, CRP",
        "Synovial fluid WBC < 50,000",
        "Blood and synovial fluid cultures sterile",
        "May be polyarticular, involve large, small, and axial joints",
        "Jones criteria for ARF not met and other causes are excluded (e.g., Lyme disease, rheumatoid arthritis)",
        "Symptoms may last for months."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Group A Streptococcus (S. pyogenes) (throat culture positive in about half of cases)."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "crossReference",
      "referenceData": {
        "text": "Treat as for Streptococcal pharyngitis",
        "targetType": "internalDocument",
        "targetIdentifier": "Streptococcal pharyngitis"
      }
    },
    {
      "type": "paragraph",
      "text": "Then, manage with NSAIDs Â± prednisone (may be required in some patients)"
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "None"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Secondary prophylaxis",
        "Cardiac involvement rare: Clin Exp Rheumatol 33:578, 2015.",
        "The patient should be followed for several months for evidence of carditis, which if observed the patient should be reclassified as having ARF and should receive secondary prophylaxis.",
        "Although one year of secondary prophylaxis is recommended by some, its utility are not well established: Circulation 2009; 119:154.",
        "Reference: Pediatr Emerg Care 28:1185, 2012; BMJ Case Reports 2016; Curr Rheumatol Rep. 2021 Feb 10;23(3):19"
      ]
    }
  ]
}
